Nordea Investment Management
WST icon

Nordea Investment Management’s West Pharmaceutical WST Stock Holding History

Nordea Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.62M Sell
21,588
-19,090
-47% -$5.84M 0.01% 512
2026
Q1 		$10M Buy
40,678
+25,728
+172% +$6.4M 0.01% 447
2025
Q4 		$4.12M Buy
14,950
+4,477
+43% +$1.22M ﹤0.01% 628
2025
Q3 		$2.73M Sell
10,473
-145
-1% -$35.2K ﹤0.01% 697
2025
Q2 		$2.35M Buy
10,618
+344
+3% +$73.5K ﹤0.01% 702
2025
Q1 		$2.28M Buy
10,274
+3,932
+62% +$1.08M ﹤0.01% 677
2024
Q4 		$2.09M Buy
6,342
+203
+3% +$63.9K ﹤0.01% 684
2024
Q3 		$1.87M Sell
6,139
-31,044
-83% -$9.51M ﹤0.01% 704
2024
Q2 		$12.4M Sell
37,183
-189
-0.5% -$66.8K 0.01% 374
2024
Q1 		$14.8M Buy
37,372
+265
+0.7% +$98K 0.02% 369
2023
Q4 		$13.1M Sell
37,107
-347
-0.9% -$123K 0.02% 369
2023
Q3 		$14.2M Sell
37,454
-617
-2% -$239K 0.02% 336
2023
Q2 		$14.6M Sell
38,071
-1,617
-4% -$578K 0.02% 345
2023
Q1 		$13.8M Buy
39,688
+513
+1% +$150K 0.02% 330
2022
Q4 		$9.17M Sell
39,175
-9,797
-20% -$2.32M 0.01% 396
2022
Q3 		$12.3M Sell
48,972
-36,047
-42% -$11M 0.02% 336
2022
Q2 		$25.3M Buy
85,019
+52,977
+165% +$17.2M 0.04% 279
2022
Q1 		$13.5M Sell
32,042
-1,896
-6% -$742K 0.02% 357
2021
Q4 		$16M Sell
33,938
-19
-0.1% -$8.18K 0.02% 342
2021
Q3 		$14.9M Sell
33,957
-982
-3% -$414K 0.02% 346
2021
Q2 		$12.5M Sell
34,939
-2,655
-7% -$877K 0.02% 358
2021
Q1 		$10.5M Buy
37,594
+1,234
+3% +$353K 0.02% 371
2020
Q4 		$10.3M Buy
36,360
+4,005
+12% +$1.12M 0.02% 358
2020
Q3 		$8.84M Buy
32,355
+23,097
+249% +$6.11M 0.02% 347
2020
Q2 		$2.04M Buy
9,258
+5,537
+149% +$1.09M ﹤0.01% 717
2020
Q1 		$582K Hold
3,721
– – ﹤0.01% 773
2019
Q4 		$564K Buy
+3,721
New +$542K ﹤0.01% 830

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nordea Investment Management's WST Position: Q2 2026 in Review

Nordea Investment Management reduced its West Pharmaceutical (WST) stake by 47% in Q2 2026, selling an estimated $5.84M and leaving 21,588 shares worth $7.62M. The position accounts for 0.01% of the portfolio, ranked #512.

Nordea Investment Management first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $25.3M in Q2 2022. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Nordea Investment Management held 21,588 shares of West Pharmaceutical worth $7.62M as of Q2 2026.
  • Nordea Investment Management sold 19,090 West Pharmaceutical shares in Q2 2026, an estimated $5.84M.
  • West Pharmaceutical made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #512 holding.
  • Nordea Investment Management first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Nordea Investment Management's West Pharmaceutical position peaked at $25.3M in Q2 2022.
  • 833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.